(PDF) Potent Activity of the HIV-1 Maturation Inhibitor

Potent Activity of the HIV-1 Maturation Inhibitor Bevirimat in SCID-hu Thy/Liv Mice

PLoS ONE - United States

doi 10.1371/journal.pone.0001251

Full Text

Open PDF

Abstract

Available in full text

Date

November 28, 2007

Authors

Publisher

Public Library of Science (PLoS)

Related search

Coinfection of SCID-hu Thy/Liv Mice With Human Herpesvirus 6 and Human Immunodeficiency Virus Type 1

English

Use of Standardized SCID-hu Thy/Liv Mouse Model for Preclinical Efficacy Testing of Anti-Human Immunodeficiency Virus Type 1 Compounds.

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

1996

English

The Prototype HIV-1 Maturation Inhibitor, Bevirimat, Binds to the CA-SP1 Cleavage Site in Immature Gag Particles

English

New Methods in Virology. Model of Viral Infection in SCID Mice: SCID-hu Mouse and Hu-PBL-Scid Mouse.

Uirusu. Journal of virology

Medicine

1999

English

Critical Contribution of Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand (Trail) to Apoptosis of Human Cd4+T Cells in HIV-1–Infected Hu-PBL-Nod-Scid Mice

Journal of Experimental Medicine

English

Trichosanthin, a Potent HIV-1 Inhibitor, Can Cleave Supercoiled DNAin Vitro

Nucleic Acids Research

Genetics

1991

English

An Intravaginal Ring for the Simultaneous Delivery of an HIV-1 Maturation Inhibitor and Reverse-Transcriptase Inhibitor for Prophylaxis of HIV Transmission

Journal of Pharmaceutical Sciences

Pharmaceutical Science

2015

English

Human Semen Contains Exosomes With Potent Anti-Hiv-1 Activity

English

T-Cell Dysfunctions in Hu-PBL-Scid Mice Infected With Human Immunodeficiency Virus (HIV) Shortly After Reconstitution: In Vivo Effects of HIV on Highly Activated Human Immune Cells.

English

Amanote Research

Potent Activity of the HIV-1 Maturation Inhibitor Bevirimat in SCID-hu Thy/Liv Mice

PLoS ONE - United States

doi 10.1371/journal.pone.0001251

Full Text

Abstract

Categories

Date

Authors

Publisher

Related search

Coinfection of SCID-hu Thy/Liv Mice With Human Herpesvirus 6 and Human Immunodeficiency Virus Type 1

Use of Standardized SCID-hu Thy/Liv Mouse Model for Preclinical Efficacy Testing of Anti-Human Immunodeficiency Virus Type 1 Compounds.

The Prototype HIV-1 Maturation Inhibitor, Bevirimat, Binds to the CA-SP1 Cleavage Site in Immature Gag Particles

New Methods in Virology. Model of Viral Infection in SCID Mice: SCID-hu Mouse and Hu-PBL-Scid Mouse.

Critical Contribution of Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand (Trail) to Apoptosis of Human Cd4+T Cells in HIV-1–Infected Hu-PBL-Nod-Scid Mice

Trichosanthin, a Potent HIV-1 Inhibitor, Can Cleave Supercoiled DNAin Vitro

An Intravaginal Ring for the Simultaneous Delivery of an HIV-1 Maturation Inhibitor and Reverse-Transcriptase Inhibitor for Prophylaxis of HIV Transmission

Human Semen Contains Exosomes With Potent Anti-Hiv-1 Activity

T-Cell Dysfunctions in Hu-PBL-Scid Mice Infected With Human Immunodeficiency Virus (HIV) Shortly After Reconstitution: In Vivo Effects of HIV on Highly Activated Human Immune Cells.